世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Point of Care & Rapid Diagnosticsの世界市場規模調査、製品別(COVID-19検査製品、グルコースモニタリング製品、心代謝モニタリング製品、感染症検査製品)、プラットフォーム別(Lateral Flow Assays、Dipsticks、マイクロ流体分子診断、免疫測定)、購入形態別(OTC製品、処方箋ベースの製品)、エンドユーザー別(臨床検査室、病院。外来診療施設および医師事務所、薬局、小売クリニック、Eコマースプラットフォーム、病院、クリティカルケアセンター、緊急医療センター、ホームケアおよび自己検査、その他のエンドユーザー)および地域別予測 2022-2028


Global Point of Care & Rapid Diagnostics Market Size study, by Product (COVID-19 test products, Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products), By platform (Lateral Flow Assays, Dipsticks, Microfluidics Molecular Diagnostics, Immunoassays), by Mode of Purchase (OTC Products, Prescription-based Products), by End-User (Clinical Laboratories. Ambulatory Care Facilities and Physician Offices, Pharmacies, retail clinics, & E-commerce Platforms, Hospitals, Critical Care Centers, Urgent care centers, Home Care & Self Testing, Other End-Users) and Regional Forecasts 2022-2028

ポイントケア&迅速診断の世界市場は、2021年に約388億9000万米ドルと評価され、予測期間2022-2028年には10.80%以上の健全な成長率で成長すると予測されています。心臓病、がん、糖尿病など、さまざまな病気の調... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング
2022年4月30日 US$4,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
200 英語

 

サマリー

ポイントケア&迅速診断の世界市場は、2021年に約388億9000万米ドルと評価され、予測期間2022-2028年には10.80%以上の健全な成長率で成長すると予測されています。心臓病、がん、糖尿病など、さまざまな病気の調査ですぐに結果を得るために利用されるポイントオブケアおよび迅速診断薬は、ポイントオブケア(POC)および迅速診断薬市場として定義されています。この市場は、政府の支援政策や感染症の高い流行といった主要な要因によって牽引されています。心臓病、肝炎、がん、消化器、呼吸器、性感染症(STD)などの慢性疾患や感染症の有病率の上昇が、世界のポイントオブケア・迅速診断市場を牽引しています。例えば、UNAIDSによると、2018年には東・南アフリカの2060万人がHIVと共存しています。中東・北アフリカでは、2019年に2万人のHIV新規感染が報告されました。さらに、2019年には、アジア太平洋地域で推定580万人がHIVに感染しており、インドと中国がその先頭を走っています。インドでは、2019年に210万人以上がHIVに感染しています。したがって、HIVの高い感染率は、ポイントオブケア診断薬および迅速診断薬の需要の増加をもたらしています。また、製品開発のための投資や資金調達の増加、新規技術に関するプロバイダーの意識の高まりは、今後数年間、有利な機会を生み出します。しかし、厳しい規制政策が、2022-2028年の予測期間における市場の成長を阻害しています。

Point of Care & Rapid Diagnosticsの世界市場分析で考慮した地域は、アジア太平洋、北米、欧州、中南米、その他の地域です。北米が市場の成長をリードし、欧州がそれに続いています。成長を支える要因としては、製品承認数の増加や生活習慣病の有病率の上昇が挙げられます。しかし、医療費の増加や疾病の早期発見に対する意識の高まりから、ラテンアメリカが最も急速に成長すると予測されています。





本レポートに含まれる主な市場プレイヤーは以下の通りです:
アボット・ラボラトリーズ
シーメンス・ヘルスィーナーズAG
クィデル株式会社
F.ホフマン・ラ・ロシュ社
ダナハーコーポレーション
ベクトン・ディッキンソン・アンド・カンパニー
チェンビオ・ダイアグノスティックス
EKFダイアグノスティックス
トリニティ・バイオテック・ピーエルシー
計測機器研究所

本調査の目的は、近年における様々なセグメント&国の市場規模を定義し、今後8年間の値を予測することです。本レポートは、本調査の対象である各地域・国において、産業の質的・量的な側面を取り込むよう設計されています。さらに、市場の将来的な成長を規定する推進要因や課題など、重要な側面に関する詳細な情報も提供しています。さらに、本レポートでは、主要企業の競争環境と製品提供の詳細な分析とともに、関係者が投資するためのミクロ市場での利用可能な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明する:
製品別
COVID-19テスト製品
グルコースモニタリング製品
カーディオメタボリックモニタリング製品
感染症検査製品
プラットフォーム別
ラテラルフローアッセイ
ディップスティック
マイクロフルイディクス
分子生物学的診断法
イムノアッセイ
購入形態別:
処方箋に基づく製品
OTC製品
エンドユーザー
臨床検査室
外来診療施設および医師事務所
薬局、小売クリニック、Eコマースプラットフォーム
病院、クリティカルケアセンター、アージェントケアセンター
ホームケア&セルフテスト
その他のエンドユーザー
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
連邦王国
ドイツ
フランス
スペイン
イタリア
ROE

アジア太平洋
中国
インド
日本
オーストラリア
南朝鮮
ロアパック
ラテンアメリカ
ブラジル
メキシコ
その他の地域

さらに、本調査で考慮した年は以下の通りです:

歴史的年号-2018年、2019年、2020年
基準年 - 2021年
予測期間 - 2022年~2028年

市場調査におけるPoint of Care & Rapid Diagnosticsの世界市場のターゲットオーディエンス:

主なコンサルティング会社・アドバイザーのご紹介
大企業・中堅企業・中小企業
ベンチャーキャピタル
付加価値再販業者(VAR)
サードパーティナレッジプロバイダー
投資銀行家
投資家の皆様へ

ページTOPに戻る


目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Point of Care & Rapid Diagnostics Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Point of Care & Rapid Diagnostics Market, by Product type, 2020-2028 (USD Billion)
1.2.3. Global Point of Care & Rapid Diagnostics Market, by Platform, 2020-2028 (USD Billion)
1.2.4. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase, 2020-2028 (USD Billion)
1.2.5. Global Point of Care & Rapid Diagnostics Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Point of Care & Rapid Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Point of Care & Rapid Diagnostics Market Dynamics
3.1. Point of Care & Rapid Diagnostics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Supportive government policies
3.1.1.2. High prevalence of infectious diseases
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory policies
3.1.2.2. Pricing pressure owing to reimbursement cuts and budget constraints
3.1.3. Market Opportunities
3.1.3.1. Growing investments and funding for product development
3.1.3.2. Increasing provider awareness about novel technologies
Chapter 4. Global Point of Care & Rapid Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Point of Care & Rapid Diagnostics Market, by Product Type
6.1. Market Snapshot
6.2. Global Point of Care & Rapid Diagnostics Market by Product Type, Performance - Potential Analysis
6.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Product Type, 2019-2028 (USD Billion)
6.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
6.4.1. COVID-19 test products
6.4.2. Glucose Monitoring Products
6.4.3. Cardiometabolic Monitoring Products
6.4.4. Infectious Disease Testing Products
Chapter 7. Global Point of Care & Rapid Diagnostics Market, by Platform
7.1. Market Snapshot
7.2. Global Point of Care & Rapid Diagnostics Market by Platform, Performance - Potential Analysis
7.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Platform, 2019-2028 (USD Billion)
7.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
7.4.1. Lateral Flow Assays
7.4.2. Dipsticks
7.4.3. Microfluidics
7.4.4. Molecular Diagnostics
7.4.5. Immunoassays
Chapter 8. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase
8.1. Market Snapshot
8.2. Global Point of Care & Rapid Diagnostics Market by Mode of Purchase, Performance - Potential Analysis
8.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Mode of Purchase, 2019-2028 (USD Billion)
8.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
8.4.1. Prescription-based Products
8.4.2. OTC Products
Chapter 9. Global Point of Care & Rapid Diagnostics Market, by End-User
9.1. Market Snapshot
9.2. Global Point of Care & Rapid Diagnostics Market by End-User, Performance - Potential Analysis
9.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by End-User, 2019-2028 (USD Billion)
9.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
9.4.1. Clinical Laboratories
9.4.2. Ambulatory Care Facilities and Physician Offices
9.4.3. Pharmacies, retail clinics, & E-commerce Platforms
9.4.4. Hospitals, Critical Care Centers, Urgent care centers
9.4.5. Home Care & Self Testing
9.4.6. Other End-Users
Chapter 10. Global Point of Care & Rapid Diagnostics Market, Regional Analysis
10.1. Point of Care & Rapid Diagnostics Market, Regional Market Snapshot
10.2. North America Point of Care & Rapid Diagnostics Market
10.2.1. U.S. Point of Care & Rapid Diagnostics Market
10.2.1.1. Product Type breakdown estimates & forecasts, 2019-2028
10.2.1.2. Platform breakdown estimates & forecasts, 2019-2028
10.2.1.3. Mode of Purchase breakdown estimates & forecasts, 2019-2028
10.2.1.4. End-User breakdown estimates & forecasts, 2019-2028
10.2.2. Canada Point of Care & Rapid Diagnostics Market
10.3. Europe Point of Care & Rapid Diagnostics Market Snapshot
10.3.1. U.K. Point of Care & Rapid Diagnostics Market
10.3.2. Germany Point of Care & Rapid Diagnostics Market
10.3.3. France Point of Care & Rapid Diagnostics Market
10.3.4. Spain Point of Care & Rapid Diagnostics Market
10.3.5. Italy Point of Care & Rapid Diagnostics Market
10.3.6. Rest of Europe Point of Care & Rapid Diagnostics Market
10.4. Asia-Pacific Point of Care & Rapid Diagnostics Market Snapshot
10.4.1. China Point of Care & Rapid Diagnostics Market
10.4.2. India Point of Care & Rapid Diagnostics Market
10.4.3. Japan Point of Care & Rapid Diagnostics Market
10.4.4. Australia Point of Care & Rapid Diagnostics Market
10.4.5. South Korea Point of Care & Rapid Diagnostics Market
10.4.6. Rest of Asia Pacific Point of Care & Rapid Diagnostics Market
10.5. Latin America Point of Care & Rapid Diagnostics Market Snapshot
10.5.1. Brazil Point of Care & Rapid Diagnostics Market
10.5.2. Mexico Point of Care & Rapid Diagnostics Market
10.6. Rest of The World Point of Care & Rapid Diagnostics Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Becton, Dickinson and Company
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Abbott Laboratories
11.2.3. F. Hoffman-La Roche Ltd.
11.2.4. Danaher Corporation
11.2.5. Instrumentation Laboratory
11.2.6. Quidel Corporation
11.2.7. Siemens Healthineers AG
11.2.8. Chembio Diagnostics
11.2.9. Trinity Biotech plc
11.2.10. EKF Diagnostics
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

 

ページTOPに戻る


 

Summary

Global Point of care & Rapid Diagnostics Market is valued at approximately USD 38.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.80% over the forecast period 2022-2028. The point of care and rapid diagnostics utilized to get an immediate result in the investigation of various diseases such as heart diseases, cancer, diabetes, and others are defined as a point of care (POC) and rapid diagnostics market. The market is driven by key factors such as supportive government policies and high prevalence of infectious diseases. The rising prevalence of chronic and infectious illnesses such as heart disease, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) is driving the global point of care and rapid diagnostics market. For instance, According to UNAIDS, 20.6 million persons in East and Southern Africa were living with HIV in 2018. In the Middle East and North Africa, 20,000 new HIV infections were reported in 2019. Moreover, in 2019, an estimated 5.8 million persons in Asia Pacific were infected with HIV, with India and China leading the way. In India, over 2.1 million persons were infected with HIV in 2019. Hence, high incidence of HIV has led to an increase in demand for point-of-care and rapid diagnostics. Also, growing investments and funding for product development and increasing provider awareness about novel technologies create lucrative opportunities in the upcoming years. However, stringent regulatory policies impede the growth of the market over the forecast period of 2022-2028.

The geographical regions considered for the global Point of Care & Rapid Diagnostics market analysis include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is leading the market growth followed by Europe. Factors supporting the growth are increase in the number of product approvals and rise in the prevalence of lifestyle diseases. However, Lain America is projected to be the fastest growing region owing to increasing healthcare expenditure, increase awareness about early detection of diseases.





Major market players included in this report are:
Abbott Laboratories
Siemens Healthineers AG
Quidel Corporation
F. Hoffman-La Roche Ltd.
Danaher Corporation
Becton, Dickinson and Company
Chembio Diagnostics
EKF Diagnostics
Trinity Biotech plc
Instrumentation Laboratory

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
COVID-19 test products
Glucose Monitoring Products
Cardiometabolic Monitoring Products
Infectious Disease Testing Products
By Platform:
Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays
By Mode of Purchase:
Prescription-based Products
OTC Products
End-User:
Clinical Laboratories
Ambulatory Care Facilities and Physician Offices
Pharmacies, retail clinics, & E-commerce Platforms
Hospitals, Critical Care Centers, Urgent care centers
Home Care & Self Testing
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Point of Care & Rapid Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors



ページTOPに戻る


Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Point of Care & Rapid Diagnostics Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Point of Care & Rapid Diagnostics Market, by Product type, 2020-2028 (USD Billion)
1.2.3. Global Point of Care & Rapid Diagnostics Market, by Platform, 2020-2028 (USD Billion)
1.2.4. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase, 2020-2028 (USD Billion)
1.2.5. Global Point of Care & Rapid Diagnostics Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Point of Care & Rapid Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Point of Care & Rapid Diagnostics Market Dynamics
3.1. Point of Care & Rapid Diagnostics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Supportive government policies
3.1.1.2. High prevalence of infectious diseases
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory policies
3.1.2.2. Pricing pressure owing to reimbursement cuts and budget constraints
3.1.3. Market Opportunities
3.1.3.1. Growing investments and funding for product development
3.1.3.2. Increasing provider awareness about novel technologies
Chapter 4. Global Point of Care & Rapid Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Point of Care & Rapid Diagnostics Market, by Product Type
6.1. Market Snapshot
6.2. Global Point of Care & Rapid Diagnostics Market by Product Type, Performance - Potential Analysis
6.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Product Type, 2019-2028 (USD Billion)
6.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
6.4.1. COVID-19 test products
6.4.2. Glucose Monitoring Products
6.4.3. Cardiometabolic Monitoring Products
6.4.4. Infectious Disease Testing Products
Chapter 7. Global Point of Care & Rapid Diagnostics Market, by Platform
7.1. Market Snapshot
7.2. Global Point of Care & Rapid Diagnostics Market by Platform, Performance - Potential Analysis
7.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Platform, 2019-2028 (USD Billion)
7.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
7.4.1. Lateral Flow Assays
7.4.2. Dipsticks
7.4.3. Microfluidics
7.4.4. Molecular Diagnostics
7.4.5. Immunoassays
Chapter 8. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase
8.1. Market Snapshot
8.2. Global Point of Care & Rapid Diagnostics Market by Mode of Purchase, Performance - Potential Analysis
8.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Mode of Purchase, 2019-2028 (USD Billion)
8.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
8.4.1. Prescription-based Products
8.4.2. OTC Products
Chapter 9. Global Point of Care & Rapid Diagnostics Market, by End-User
9.1. Market Snapshot
9.2. Global Point of Care & Rapid Diagnostics Market by End-User, Performance - Potential Analysis
9.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by End-User, 2019-2028 (USD Billion)
9.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis
9.4.1. Clinical Laboratories
9.4.2. Ambulatory Care Facilities and Physician Offices
9.4.3. Pharmacies, retail clinics, & E-commerce Platforms
9.4.4. Hospitals, Critical Care Centers, Urgent care centers
9.4.5. Home Care & Self Testing
9.4.6. Other End-Users
Chapter 10. Global Point of Care & Rapid Diagnostics Market, Regional Analysis
10.1. Point of Care & Rapid Diagnostics Market, Regional Market Snapshot
10.2. North America Point of Care & Rapid Diagnostics Market
10.2.1. U.S. Point of Care & Rapid Diagnostics Market
10.2.1.1. Product Type breakdown estimates & forecasts, 2019-2028
10.2.1.2. Platform breakdown estimates & forecasts, 2019-2028
10.2.1.3. Mode of Purchase breakdown estimates & forecasts, 2019-2028
10.2.1.4. End-User breakdown estimates & forecasts, 2019-2028
10.2.2. Canada Point of Care & Rapid Diagnostics Market
10.3. Europe Point of Care & Rapid Diagnostics Market Snapshot
10.3.1. U.K. Point of Care & Rapid Diagnostics Market
10.3.2. Germany Point of Care & Rapid Diagnostics Market
10.3.3. France Point of Care & Rapid Diagnostics Market
10.3.4. Spain Point of Care & Rapid Diagnostics Market
10.3.5. Italy Point of Care & Rapid Diagnostics Market
10.3.6. Rest of Europe Point of Care & Rapid Diagnostics Market
10.4. Asia-Pacific Point of Care & Rapid Diagnostics Market Snapshot
10.4.1. China Point of Care & Rapid Diagnostics Market
10.4.2. India Point of Care & Rapid Diagnostics Market
10.4.3. Japan Point of Care & Rapid Diagnostics Market
10.4.4. Australia Point of Care & Rapid Diagnostics Market
10.4.5. South Korea Point of Care & Rapid Diagnostics Market
10.4.6. Rest of Asia Pacific Point of Care & Rapid Diagnostics Market
10.5. Latin America Point of Care & Rapid Diagnostics Market Snapshot
10.5.1. Brazil Point of Care & Rapid Diagnostics Market
10.5.2. Mexico Point of Care & Rapid Diagnostics Market
10.6. Rest of The World Point of Care & Rapid Diagnostics Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Becton, Dickinson and Company
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Abbott Laboratories
11.2.3. F. Hoffman-La Roche Ltd.
11.2.4. Danaher Corporation
11.2.5. Instrumentation Laboratory
11.2.6. Quidel Corporation
11.2.7. Siemens Healthineers AG
11.2.8. Chembio Diagnostics
11.2.9. Trinity Biotech plc
11.2.10. EKF Diagnostics
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Bizwit Research & Consulting LLP社の医療デバイス・機器分野での最新刊レポート

本レポートと同じKEY WORD(diagnostics)の最新刊レポート


よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る